| Treating Clostridium difficile infection with fecal microbiota transplantation JS Bakken, T Borody, LJ Brandt, JV Brill, DC Demarco, MA Franzos, ... Clinical gastroenterology and hepatology 9 (12), 1044-1049, 2011 | 1328 | 2011 |
| Long-term follow-up of colonoscopic fecal microbiota transplant for recurrentclostridium difficileinfection LJ Brandt, OC Aroniadis, M Mellow, A Kanatzar, C Kelly, T Park, ... Official journal of the American College of Gastroenterology| ACG 107 (7 …, 2012 | 960 | 2012 |
| Fecal Microbiota Transplant for Treatment ofClostridium difficileInfection in Immunocompromised Patients CR Kelly, C Ihunnah, M Fischer, A Khoruts, C Surawicz, A Afzali, ... Official journal of the American College of Gastroenterology| ACG 109 (7 …, 2014 | 770 | 2014 |
| Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook CR Kelly, S Kahn, P Kashyap, L Laine, D Rubin, A Atreja, T Moore, G Wu Gastroenterology 149 (1), 223-237, 2015 | 745 | 2015 |
| Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial CR Kelly, A Khoruts, C Staley, MJ Sadowsky, M Abd, M Alani, B Bakow, ... Annals of internal medicine 165 (9), 609-616, 2016 | 700 | 2016 |
| Weight gain after fecal microbiota transplantation N Alang, CR Kelly Open forum infectious diseases 2 (1), ofv004, 2015 | 565 | 2015 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 458 | 2019 |
| ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections CR Kelly, M Fischer, JR Allegretti, K LaPlante, DB Stewart, BN Limketkai, ... Official journal of the American College of Gastroenterology| ACG 116 (6 …, 2021 | 443 | 2021 |
| A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection S Khanna, DS Pardi, CR Kelly, CS Kraft, T Dhere, MR Henn, ... The Journal of infectious diseases 214 (2), 173-181, 2016 | 375 | 2016 |
| The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications JR Allegretti, BH Mullish, C Kelly, M Fischer The Lancet 394 (10196), 420-431, 2019 | 342 | 2019 |
| Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection LM De Leon, JB Watson, CR Kelly Clinical Gastroenterology and Hepatology 11 (8), 1036-1038, 2013 | 283 | 2013 |
| Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice M Yao, S Kargman, EC Lam, CR Kelly, Y Zheng, P Luk, E Kwong, ... Cancer research 63 (3), 586-592, 2003 | 279 | 2003 |
| Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results CR Kelly, L de Leon, N Jasutkar Journal of clinical gastroenterology 46 (2), 145-149, 2012 | 273 | 2012 |
| Policy: How to regulate faecal transplants MB Smith, C Kelly, EJ Alm Nature 506 (7488), 290-291, 2014 | 218 | 2014 |
| The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals M Agrawal, OC Aroniadis, LJ Brandt, C Kelly, S Freeman, C Surawicz, ... Journal of clinical gastroenterology 50 (5), 403-407, 2016 | 217 | 2016 |
| Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease M Fischer, D Kao, C Kelly, A Kuchipudi, SM Jafri, M Blumenkehl, D Rex, ... Inflammatory bowel diseases 22 (10), 2402-2409, 2016 | 195 | 2016 |
| Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry CR Kelly, EF Yen, AM Grinspan, SA Kahn, A Atreja, JD Lewis, TA Moore, ... Gastroenterology 160 (1), 183-192. e3, 2021 | 186 | 2021 |
| Systematic review: the global incidence of faecal microbiota transplantation‐related adverse events from 2000 to 2020 C Marcella, B Cui, CR Kelly, G Ianiro, G Cammarota, F Zhang Alimentary pharmacology & therapeutics 53 (1), 33-42, 2021 | 184 | 2021 |
| Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel G Ianiro, BH Mullish, CR Kelly, H Sokol, Z Kassam, SC Ng, M Fischer, ... The lancet Gastroenterology & hepatology 5 (5), 430-432, 2020 | 161 | 2020 |
| Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer M Yao, EC Lam, CR Kelly, W Zhou, MM Wolfe British journal of cancer 90 (3), 712-719, 2004 | 161 | 2004 |
Monika FischerAssociate Professor of MedicineVerified email at iu.edu
